Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG)

作者: Christine M Laine , Boi-Dinh Chung , Miki Susic , T Prescott , Oliver Semler

DOI: 10.1038/EJHG.2011.42

关键词:

摘要: Osteoporosis-pseudoglioma sydrome (OPPG) is an autosomal recessive disorder with early-onset severe osteoporosis and blindness, caused by biallelic loss-of-function mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) gene. Heterozygous carriers exhibit a milder bone phenotype. Only few splice LRP5 have been published. We present clinical genetic data for four patients novel mutations, three of which affect splicing. Patients were evaluated clinically radiography densitometry. Genetic screening was performed on basis diagnosis OPPG. Splice aberrances confirmed cDNA sequencing or exon trapping. The effect one mutation function studied. A splice-site c.1584+4A>T abolished donor site 7 activated cryptic site, led to in-frame insertion 21 amino acids (p.E528_V529ins21). Functional studies revealed severely impaired signal transduction presumably defective intracellular transport mutated receptor. Exon trapping used two samples confirm that c.4112-2A>G c.1015+1G>T splicing-out exons 20 5, respectively. One patient carried homozygous deletion 4 causing loss as demonstrated analysis. Our results broaden spectrum provide first functional aberrations.

参考文章(38)
Miikka Vikkula, P Beighton, L Boon, M J van den Boogaard, R Ramesar, B Steinmann, T Hirose, B R Olsen, A De Paepe, Y Gong, M L Warman, B Dallapiccola, W Adkins, A Jans, W Swoboda, H Somer, R G Boles, J Liu, H G Brunner, L Peltonen, B Zabel, A Superti-Furga, Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13 American Journal of Human Genetics. ,vol. 59, pp. 146- 151 ,(1996)
Fahri Bayram, Fatih Tanriverdi, Selim Kurtoglu, M Emre Atabek, Mustafa Kula, Leyla Kaynar, Fahrettin Keleştimur, None, Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG). Journal of Pediatric Endocrinology and Metabolism. ,vol. 19, pp. 275- 279 ,(2006) , 10.1515/JPEM.2006.19.3.275
Elizabeth A. Streeten, Daniel McBride, Eric Puffenberger, Marc E. Hoffman, Toni I. Pollin, Patrick Donnelly, Paul Sack, Holmes Morton, Osteoporosis-pseudoglioma syndrome: Description of 9 new cases and beneficial response to bisphosphonates Bone. ,vol. 43, pp. 584- 590 ,(2008) , 10.1016/J.BONE.2008.04.020
Heini Hartikka, Outi Mäkitie, Minna Männikkö, Andrea S Doria, Alan Daneman, William G Cole, Leena Ala-Kokko, Etienne B Sochett, Heterozygous Mutations in the LDL Receptor‐Related Protein 5 (LRP5) Gene Are Associated With Primary Osteoporosis in Children Journal of Bone and Mineral Research. ,vol. 20, pp. 783- 789 ,(2005) , 10.1359/JBMR.050101
Anne Saarinen, Tero Saukkonen, Tero Kivelä, Ulla Lahtinen, Christine Laine, Mirja Somer, Sanna Toiviainen-Salo, William G. Cole, Anna-Elina Lehesjoki, Outi Mäkitie, Low density lipoprotein receptor‐related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia Clinical Endocrinology. ,vol. 72, pp. 481- 488 ,(2010) , 10.1111/J.1365-2265.2009.03680.X
Anne-Marie Sims, Neil Shephard, Kim Carter, Tracy Doan, Alison Dowling, Emma L Duncan, John Eisman, Graeme Jones, Geoffrey Nicholson, Richard Prince, Ego Seeman, Gethin Thomas, John A Wass, Matthew A Brown, Genetic analyses in a sample of individuals with high or low BMD shows association with multiple Wnt pathway genes. Journal of Bone and Mineral Research. ,vol. 23, pp. 499- 506 ,(2007) , 10.1359/JBMR.071113
Satoshi Narumi, Chikahiko Numakura, Takashi Shiihara, Chizuru Seiwa, Yasuyuki Nozaki, Takanori Yamagata, Mariko Y. Momoi, Yoriko Watanabe, Makoto Yoshino, Toyojiro Matsuishi, Eriko Nishi, Hiroshi Kawame, Tsutomu Akahane, Gen Nishimura, Mitsuru Emi, Tomonobu Hasegawa, Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray American Journal of Medical Genetics Part A. ,vol. 152, pp. 133- 140 ,(2010) , 10.1002/AJMG.A.33177
Randall D. Little, Colleen Folz, Susan P. Manning, Pamela M. Swain, Shan-Chuan Zhao, Brenda Eustace, Michelle M. Lappe, Lia Spitzer, Susan Zweier, Karen Braunschweiger, Youssef Benchekroun, Xintong Hu, Ronald Adair, Linda Chee, Michael G. FitzGerald, Craig Tulig, Anthony Caruso, Nia Tzellas, Alicia Bawa, Barbara Franklin, Shannon McGuire, Xavier Nogues, Gordon Gong, Kristina M. Allen, Anthony Anisowicz, Arturo J. Morales, Peter T. Lomedico, Susan M. Recker, Paul Van Eerdewegh, Robert R. Recker, John P. Carulli, Richard G. Del Mastro, Josée Dupuis, Mark Osborne, Mark L. Johnson, A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. American Journal of Human Genetics. ,vol. 70, pp. 11- 19 ,(2002) , 10.1086/338450
Liesbeth Van Wesenbeeck, Erna Cleiren, Jeppe Gram, Rodney K. Beals, Olivier Bénichou, Domenico Scopelliti, Lyndon Key, Tara Renton, Cindy Bartels, Yaoqin Gong, Matthew L. Warman, Marie-Christine de Vernejoul, Jens Bollerslev, Wim Van Hul, Six Novel Missense Mutations in the LDL Receptor-Related Protein 5 (LRP5) Gene in Different Conditions with an Increased Bone Density American Journal of Human Genetics. ,vol. 72, pp. 763- 771 ,(2003) , 10.1086/368277
Patricia Crabbe, Wendy Balemans, Andy Willaert, Inge Van Pottelbergh, Erna Cleiren, Paul J Coucke, Minrong Ai, Stefan Goemaere, Wim Van Hul, Anne De Paepe, Jean-Marc Kaufman, Missense mutations in LRP5 are not a common cause of idiopathic osteoporosis in adult men Journal of Bone and Mineral Research. ,vol. 20, pp. 1951- 1959 ,(2005) , 10.1359/JBMR.050705